Briggs Duncan W. Morrison
Independent Chairman & Lead DirectorDr. Briggs Duncan W. Morrison, M.D., Ph.D., is Chair of the Board of Actithera, Inc. from September 2026. Dr. Morrison is a member of the board of directors of CRISPR Therapeutics. A medical oncologist with many years of experience in the pharmaceutical and biotechnology industries, he previously held executive leadership positions at Syndax Pharmaceuticals, AstraZeneca, Pfizer and Merck, where he oversaw the clinical development of numerous oncology medicines, including Tagrisso®, Imfinzi® and Lynparza®. Dr. Morrison was Chairman of Scientific Advisory Board of Transcenta Holding Limited. Dr. Morrison is Chairman of Arvinas, Inc. from February 12, 2026. Dr. Morrison is Lead Independent Director of Arvinas, Inc. from June 15, 2023. Dr. Morrison is Director of Werewolf Therapeutics, Inc. Dr. Morrison was Independent Director of Arvinas, Inc. until June 15, 2023. Dr. Morrison served as an Independent Director at Carisma Therapeutics, Inc. since March 7, 2023 until October 15, 2025. He is Independent Director of CRISPR Therapeutics AG from June 5, 2025. He is President, CEO & Director of Crossbow Therapeutics, Inc. He has served as Crossbow’s Chief Executive Officer and as a member of the Board of Directors since February 2022. He is trained as a medical oncologist and has been in the?biopharmaceutical industry for many years. He has overseen the clinical development from Phase 1 through to approval and life cycle management of many approved drugs, including Tagrisso®, Imfinzi® and Lynparza®. ?He serves on the Board of Directors of a number of public and private biotechnology companies and is an Executive Partner at MPM Capital.? He received his B.S. in?Biology from Georgetown University and his M.D. from the University of Connecticut.
公司職務
- 公司名稱Arvinas, Inc.股票代碼ARVN職務Independent Chairman & Lead Director共事同僚
- ARAndrew R. SaikCFO & Treasurer
- BDBriggs Duncan W. MorrisonIndependent Chairman & Lead Director
- AMAngela M. CacaceChief Scientific Officer
- RTRandy TeelCEO, President & Director
- DKDavid K. LoomisVP & Chief Accounting Officer
- JBJeff BoyleVice President of Investor Relations
- ITIan TaylorChairman of Scientific Advisory Board
- EMEdward Moore KennedyIndependent Director
- LVLeslie V. NorwalkIndependent Director
- 公司名稱Werewolf Therapeutics, Inc.股票代碼HOWL職務Director
